Home

היזהר האקדמיה יהלום less administrations and lower doses שלישית לבלוע ממוצע

emDOCs.net – Emergency Medicine EducationPush-Dose Vasopressors: An Update  for 2019 - emDOCs.net - Emergency Medicine Education
emDOCs.net – Emergency Medicine EducationPush-Dose Vasopressors: An Update for 2019 - emDOCs.net - Emergency Medicine Education

Epidural: What It Is, Procedure, Risks & Side Effects
Epidural: What It Is, Procedure, Risks & Side Effects

Near-Equivalence: Generating Evidence to Support Alternative Cost-Effective  Treatments | Journal of Clinical Oncology
Near-Equivalence: Generating Evidence to Support Alternative Cost-Effective Treatments | Journal of Clinical Oncology

Parenteral Route: What Is It, Methods of Administration, Advantages,  Disadvantages, and More | Osmosis
Parenteral Route: What Is It, Methods of Administration, Advantages, Disadvantages, and More | Osmosis

DepoDur™: A New Drug Formulation With Unique Safety Considerations -  Anesthesia Patient Safety Foundation
DepoDur™: A New Drug Formulation With Unique Safety Considerations - Anesthesia Patient Safety Foundation

Coronavirus (COVID-19) Update: FDA Shortens Interval for Booster Dose of  Moderna COVID-19 Vaccine to Five Months | FDA
Coronavirus (COVID-19) Update: FDA Shortens Interval for Booster Dose of Moderna COVID-19 Vaccine to Five Months | FDA

Interim Estimates of Vaccine Effectiveness of BNT162b2 and mRNA-1273  COVID-19 Vaccines in Preventing SARS-CoV-2 Infection Among Health Care  Personnel, First Responders, and Other Essential and Frontline Workers —  Eight U.S. Locations, December
Interim Estimates of Vaccine Effectiveness of BNT162b2 and mRNA-1273 COVID-19 Vaccines in Preventing SARS-CoV-2 Infection Among Health Care Personnel, First Responders, and Other Essential and Frontline Workers — Eight U.S. Locations, December

Periprocedural Guidelines for the Management of Patients on long-term  Anticoagulant and Antiplatelet Agents
Periprocedural Guidelines for the Management of Patients on long-term Anticoagulant and Antiplatelet Agents

Carbidopa/ Levodopa Extended Release Capsules (Rytary) Criteria for Use  October 2015
Carbidopa/ Levodopa Extended Release Capsules (Rytary) Criteria for Use October 2015

Update on Common Psychiatric Medications for Children | Pediatric Annals
Update on Common Psychiatric Medications for Children | Pediatric Annals

Warfarin Therapy: Evolving Strategies in Anticoagulation | AAFP
Warfarin Therapy: Evolving Strategies in Anticoagulation | AAFP

Efficacy of a low-dose candidate malaria vaccine, R21 in adjuvant Matrix-M,  with seasonal administration to children in Burkina Faso: a randomised  controlled trial - The Lancet
Efficacy of a low-dose candidate malaria vaccine, R21 in adjuvant Matrix-M, with seasonal administration to children in Burkina Faso: a randomised controlled trial - The Lancet

Dosing & Prescribing | Ozempic® (semaglutide) injection 0.5 mg, 1 mg, or 2  mg
Dosing & Prescribing | Ozempic® (semaglutide) injection 0.5 mg, 1 mg, or 2 mg

Dosing and Administration - NEXIUM® (esomeprazole magnesium) | For HCPs
Dosing and Administration - NEXIUM® (esomeprazole magnesium) | For HCPs

Benefit of full-dose heparin for patients with COVID-19 warrants 'new  standard of care'
Benefit of full-dose heparin for patients with COVID-19 warrants 'new standard of care'

Lower-dose prescribing: Minimizing “side effects” of pharmaceuticals on  society and the environment - ScienceDirect
Lower-dose prescribing: Minimizing “side effects” of pharmaceuticals on society and the environment - ScienceDirect

Real-World Midazolam Use and Outcomes With Out-of-Hospital Treatment of  Status Epilepticus in the United States
Real-World Midazolam Use and Outcomes With Out-of-Hospital Treatment of Status Epilepticus in the United States

Pinkbook: Vaccine Administration | CDC
Pinkbook: Vaccine Administration | CDC

Peaks and Troughs: What Are They, and More | Osmosis
Peaks and Troughs: What Are They, and More | Osmosis

Low immunogenicity of LNP allows repeated administrations of CRISPR-Cas9  mRNA into skeletal muscle in mice | Nature Communications
Low immunogenicity of LNP allows repeated administrations of CRISPR-Cas9 mRNA into skeletal muscle in mice | Nature Communications

Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19 |  NEJM
Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19 | NEJM

Dosing for ZERBAXA® (ceftolozane and tazobactam) | Official Site
Dosing for ZERBAXA® (ceftolozane and tazobactam) | Official Site

Evaluation of mortality attributable to SARS-CoV-2 vaccine administration  using national level data from Qatar | Nature Communications
Evaluation of mortality attributable to SARS-CoV-2 vaccine administration using national level data from Qatar | Nature Communications

Dosing & Prescribing | Ozempic® (semaglutide) injection 0.5 mg, 1 mg, or 2  mg
Dosing & Prescribing | Ozempic® (semaglutide) injection 0.5 mg, 1 mg, or 2 mg